<VariationArchive VariationID="504213" VariationName="NM_001386393.1(PANK2):c.175_182del (p.Ser59fs)" VariationType="Deletion" Accession="VCV000504213" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-04-06" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="495744" VariationID="504213">
      <GeneList>
        <Gene Symbol="LOC130065345" FullName="ATAC-STARR-seq lymphoblastoid silent region 12635" GeneID="130065345" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3889272" stop="3889771" display_start="3889272" display_stop="3889771" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PANK2" FullName="pantothenate kinase 2" GeneID="80025" HGNC_ID="HGNC:15894" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3888781" stop="3929887" display_start="3888781" display_stop="3929887" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3869485" stop="3904501" display_start="3869485" display_stop="3904501" Strand="+" />
          </Location>
          <OMIM>606157</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001386393.1(PANK2):c.175_182del (p.Ser59fs)</Name>
      <CanonicalSPDI>NC_000020.11:3889603:CAGCGCGTC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3889604" stop="3889611" display_start="3889604" display_stop="3889611" variantLength="8" positionVCF="3889603" referenceAlleleVCF="GCAGCGCGT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3870251" stop="3870258" display_start="3870251" display_stop="3870258" variantLength="8" positionVCF="3870250" referenceAlleleVCF="GCAGCGCGT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>S169fs</ProteinChange>
      <ProteinChange>S59fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.3870252_3870259del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.3870252_3870259del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.3889605_3889612del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.3889605_3889612del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008131.3" sequenceAccession="NG_008131" sequenceVersion="3" change="g.5767_5774del">
            <Expression>NG_008131.3:g.5767_5774del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324191.2" sequenceAccession="NM_001324191" sequenceVersion="2" change="c.-537_-530del">
            <Expression>NM_001324191.2:c.-537_-530del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001324192.1" sequenceAccession="NM_001324192" sequenceVersion="1" change="c.505_512del">
            <Expression>NM_001324192.1:c.505_512del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001311121.1" sequenceAccession="NP_001311121" sequenceVersion="1" change="p.Ser169fs">
            <Expression>NP_001311121.1:p.Ser169fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386393.1" sequenceAccession="NM_001386393" sequenceVersion="1" change="c.175_182del" MANESelect="true">
            <Expression>NM_001386393.1:c.175_182del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001373322.1" sequenceAccession="NP_001373322" sequenceVersion="1" change="p.Ser59fs">
            <Expression>NP_001373322.1:p.Ser59fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153638.4" sequenceAccession="NM_153638" sequenceVersion="4" change="c.505_512del">
            <Expression>NM_153638.4:c.505_512del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_705902.2" sequenceAccession="NP_705902" sequenceVersion="2" change="p.Ser169fs">
            <Expression>NP_705902.2:p.Ser169fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_136715.2" sequenceAccession="NR_136715" sequenceVersion="2" change="n.219_226del">
            <Expression>NR_136715.2:n.219_226del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024960.6" sequenceAccession="NM_024960" sequenceVersion="6" change="c.-246+701_-246+708del">
            <Expression>NM_024960.6:c.-246+701_-246+708del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1016" sequenceAccession="LRG_1016">
            <Expression>LRG_1016:g.5767_5774del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1016t2" sequenceAccession="LRG_1016t2">
            <Expression>LRG_1016t2:c.175_182del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1016p2" sequenceAccession="LRG_1016p2" change="p.Ser59fs">
            <Expression>LRG_1016p2:p.Ser59fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1016t1" sequenceAccession="LRG_1016t1">
            <Expression>LRG_1016t1:c.505_512del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1016p1" sequenceAccession="LRG_1016p1" change="p.Ser169fs">
            <Expression>LRG_1016p1:p.Ser169fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA9750591" DB="ClinGen" />
        <XRef Type="rs" ID="755653150" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001386393.1(PANK2):c.175_182del (p.Ser59fs) AND not provided" Accession="RCV000598553" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-01-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001386393.1(PANK2):c.175_182del (p.Ser59fs) AND Pigmentary pallidal degeneration" Accession="RCV000990270" Version="6">
        <ClassifiedConditionList TraitSetID="1251">
          <ClassifiedCondition DB="MedGen" ID="C0018523">Pigmentary pallidal degeneration</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-15" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001386393.1(PANK2):c.175_182del (p.Ser59fs) AND multiple conditions" Accession="RCV002506443" Version="1">
        <ClassifiedConditionList TraitSetID="9763">
          <ClassifiedCondition DB="MedGen" ID="C1846582">Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0018523">Pigmentary pallidal degeneration</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-15" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2018-04-02" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11479594</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12510040</ID>
        </Citation>
        <DescriptionHistory Dated="2020-01-08">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9763" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2393" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration</ElementValue>
                <XRef ID="HARP+Syndrome/3244" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011798" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">HARP Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pantothenate kinase-associated neurodegeneration (PKAN) is a type of neurodegeneration with brain iron accumulation (NBIA). The phenotypic spectrum of PKAN includes classic PKAN and atypical PKAN. Classic PKAN is characterized by early-childhood onset of progressive dystonia, dysarthria, rigidity, and choreoathetosis. Pigmentary retinal degeneration is common. Atypical PKAN is characterized by later onset (age &gt;10 years), prominent speech defects, psychiatric disturbances, and more gradual progression of disease.</Attribute>
                <XRef ID="NBK1490" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301663</ID>
                <ID Source="BookShelf">NBK1490</ID>
              </Citation>
              <XRef ID="C1846582" DB="MedGen" />
              <XRef ID="MONDO:0011798" DB="MONDO" />
            </Trait>
            <Trait ID="3087" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neuroaxonal dystrophy, late infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hallervorden-Spatz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pigmentary pallidal degeneration</ElementValue>
                <XRef ID="Pigmentary+pallidal+degeneration/9108" DB="Genetic Alliance" />
                <XRef ID="2992000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HARP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pantothenate kinase-associated neurodegeneration</ElementValue>
                <XRef ID="MONDO:0009319" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA1</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKAN</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HARP</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6564" />
                <XRef ID="6564" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pantothenate kinase-associated neurodegeneration (PKAN) is a type of neurodegeneration with brain iron accumulation (NBIA). The phenotypic spectrum of PKAN includes classic PKAN and atypical PKAN. Classic PKAN is characterized by early-childhood onset of progressive dystonia, dysarthria, rigidity, and choreoathetosis. Pigmentary retinal degeneration is common. Atypical PKAN is characterized by later onset (age &gt;10 years), prominent speech defects, psychiatric disturbances, and more gradual progression of disease.</Attribute>
                <XRef ID="NBK1490" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301663</ID>
                <ID Source="BookShelf">NBK1490</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157850" DB="Orphanet" />
              <XRef ID="C0018523" DB="MedGen" />
              <XRef ID="MONDO:0009319" DB="MONDO" />
              <XRef Type="MIM" ID="234200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3087" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neuroaxonal dystrophy, late infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hallervorden-Spatz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pigmentary pallidal degeneration</ElementValue>
                <XRef ID="Pigmentary+pallidal+degeneration/9108" DB="Genetic Alliance" />
                <XRef ID="2992000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HARP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pantothenate kinase-associated neurodegeneration</ElementValue>
                <XRef ID="MONDO:0009319" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NBIA1</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PKAN</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HARP</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6564" />
                <XRef ID="6564" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pantothenate kinase-associated neurodegeneration (PKAN) is a type of neurodegeneration with brain iron accumulation (NBIA). The phenotypic spectrum of PKAN includes classic PKAN and atypical PKAN. Classic PKAN is characterized by early-childhood onset of progressive dystonia, dysarthria, rigidity, and choreoathetosis. Pigmentary retinal degeneration is common. Atypical PKAN is characterized by later onset (age &gt;10 years), prominent speech defects, psychiatric disturbances, and more gradual progression of disease.</Attribute>
                <XRef ID="NBK1490" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301663</ID>
                <ID Source="BookShelf">NBK1490</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157850" DB="Orphanet" />
              <XRef ID="C0018523" DB="MedGen" />
              <XRef ID="MONDO:0009319" DB="MONDO" />
              <XRef Type="MIM" ID="234200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1390531" SubmissionDate="2019-01-29" DateLastUpdated="2018-04-02" DateCreated="2018-04-02">
        <ClinVarSubmissionID localKey="GDX:1913795|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000710525" DateUpdated="2018-04-02" DateCreated="2018-04-02" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.505_512delAGCGCGTC variant in the PANK2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.505_512delAGCGCGTC variant causes a frameshift starting with codon Serine 169, changes this amino acid to a Glycine residue, andcreates a premature Stop codon at position 9 of the new reading frame, denoted p.Ser169GlyfsX9. This variant is predicted to cause loss of normal protein function either through protein truncation ornonsense-mediated mRNA decay. The c.505_512delAGCGCGTC variant is observed in 4/22184(0.02%) alleles from individuals of Latino background, in large population cohorts (Lek et al., 2016). We interpret c.505_512delAGCGCGTC as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PANK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153638.2:c.505_512delAGCGCGTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2247001" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000020.10:g.3870251_3870258delCAGCGCGT|OMIM:234200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001141198" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PANK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.3870251_3870258delCAGCGCGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="234200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5462242" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_153638.3:c.505_512del|OMIM:234200;607236" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002804934" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153638.3:c.505_512del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="234200" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607236" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4247554" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4802510|MedGen:C0018523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002235087" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11479594</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12510040</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser169Glyfs*9) in the PANK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PANK2 are known to be pathogenic (PMID: 11479594, 12510040). This variant is present in population databases (rs755653150, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PANK2-related conditions. ClinVar contains an entry for this variant (Variation ID: 504213). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PANK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.3870251_3870258del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0018523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5462242" TraitType="Disease" MappingType="XRef" MappingValue="607236" MappingRef="OMIM">
        <MedGen CUI="C0018523" Name="Pigmentary pallidal degeneration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1390531" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4247554" TraitType="Disease" MappingType="XRef" MappingValue="C0018523" MappingRef="MedGen">
        <MedGen CUI="C0018523" Name="Pigmentary pallidal degeneration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5462242" TraitType="Disease" MappingType="XRef" MappingValue="234200" MappingRef="OMIM">
        <MedGen CUI="C0018523" Name="Pigmentary pallidal degeneration" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2247001" TraitType="Disease" MappingType="XRef" MappingValue="234200" MappingRef="OMIM">
        <MedGen CUI="C0018523" Name="Pigmentary pallidal degeneration" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-05-28">SCV001523940</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

